Peptide research,
organized.

Yes — for in-vitro research at registered institutions. The compounds discussed across this library are sold and shipped as research-only material, not as drugs or supplements. Most jurisdictions allow ownership of research-grade peptides for laboratory work; what's typically restricted is human or veterinary administration outside of an authorised clinical trial. Local rules vary, so the practical advice is: check your jurisdiction's controlled-substances list and your institution's IRB / ethics framework before ordering anything.

Prescription peptides (e.g. semaglutide, octreotide, calcitonin) are pharmaceutical-grade preparations approved by a regulator for a specific human indication. Research peptides are the same molecules — or close analogues — manufactured for laboratory use, where the manufacturing standard is purity-and-identity verification rather than full GMP human-use compliance. Same chemistry; different supply chain; different intended use.

Most of them, yes. The library leans toward open-access and Creative Commons journals (Cureus, Frontiers, MDPI, Cell Press open access). For the rest, the DOI on each citation card is the canonical link — most major institutions and many public libraries have access. PubMed Central often has an open-access version where the publisher's page is paywalled.

The library indexes papers across the past two decades — foundational work from the 1990s and 2000s for areas like longevity (where the rodent literature is older), and 2024–2026 work for areas where the field is moving fast. New entries are added as they're published; the editorial articles update their citation chain when newer papers materially change the picture.

Mechanism-class language — 'regenerative-peptide pathway', 'mitochondrial multitasker', 'cognitive-support short peptide' — reflects how the literature actually frames the science. Most published research groups peptides by what they signal, not by trade name. Specific compound names appear in the research library entries where they belong, in the Vancouver references and DOI links.

No. Nothing on this site constitutes medical advice, dosing guidance, or a treatment recommendation. The library covers research, mechanism, and the editorial framing of the published literature. If you're translating any of this into a clinical or research-practice decision, the right next step is a qualified physician, principal investigator, or institutional review process.

Peptidoteca is editorially independent of Readypep, the United-Kingdom-based authorised distributor of Metatide Healthcare research peptide dispensers. Readypep is the destination we link to for readers whose research progresses past the editorial layer; the editorial calendar isn't driven by Readypep's commercial decisions, and Readypep doesn't review what's published here before publication.

Email corrections@peptidoteca.com with the article slug, the citation ID, and the specific issue. Replies typically land within five business days, and corrections (or take-downs, if a citation can't be re-validated) are issued within ten business days.